Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Big Sky Oncology
mi
from
Great Falls, MT
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Big Sky Oncology
mi
from
Great Falls, MT
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Sletten Cancer Institute at Benefis Healthcare
mi
from
Great Falls, MT
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Immanuel Medical Center
mi
from
Omaha, NE
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Immanuel Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Creighton University Medical Center
mi
from
Omaha, NE
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Bismarck Cancer Center
mi
from
Bismarck, ND
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Bismarck Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Medcenter One Hospital Cancer Care Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Mid Dakota Clinic, PC
mi
from
Bismarck, ND
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
St. Alexius Medical Center Cancer Center
mi
from
Bismarck, ND
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Grandview Hospital
mi
from
Dayton, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Grandview Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Good Samaritan Hospital
mi
from
Dayton, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Good Samaritan Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
David L. Rike Cancer Center at Miami Valley Hospital
mi
from
Dayton, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Samaritan North Cancer Care Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
CCOP - Dayton
mi
from
Dayton, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
CCOP - Dayton
mi
from
Dayton, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Blanchard Valley Medical Associates
mi
from
Findlay, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Middletown Regional Hospital
mi
from
Franklin, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Middletown Regional Hospital
mi
from
Franklin, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Wayne Hospital
mi
from
Greenville, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Wayne Hospital
mi
from
Greenville, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Charles F. Kettering Memorial Hospital
mi
from
Kettering, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
UVMC Cancer Care Center at Upper Valley Medical Center
mi
from
Troy, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
UVMC Cancer Care Center at Upper Valley Medical Center
mi
from
Troy, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Clinton Memorial Hospital
mi
from
Wilmington, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Clinton Memorial Hospital
mi
from
Wilmington, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Ruth G. McMillan Cancer Center at Greene Memorial Hospital
mi
from
Xenia, OH
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
mi
from
Allentown, PA
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
mi
from
Allentown, PA
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/9/2015
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Gemcitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
Phase II Trial of Albumin-Bound Paclitaxel in Combination With Gemcitabine and Bevacizumab in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/9/2015
Sanford Cancer Center at Sanford USD Medical Center
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer
Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer
Status: Enrolling
Updated:  7/10/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer
Efficacy of Acupuncture for Hot Flashes in Women Treated With Hormonal Therapy for Breast Cancer
Status: Enrolling
Updated: 7/10/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
Trial for Locally Advanced Her2 Positive Breast Cancer Using Paclitaxel, Trastuzumab, Doxorubicin and Cyclophasmide on a Weekly Basis
Phase I-II Trial of Vorinostat Plus Weekly Paclitaxel and Trastuzumab Followed by Doxorubicin-cyclophosphamide in Patients With Locally Advanced Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Montefiore Medical Center
mi
from
Bronx, NY
Trial for Locally Advanced Her2 Positive Breast Cancer Using Paclitaxel, Trastuzumab, Doxorubicin and Cyclophasmide on a Weekly Basis
Phase I-II Trial of Vorinostat Plus Weekly Paclitaxel and Trastuzumab Followed by Doxorubicin-cyclophosphamide in Patients With Locally Advanced Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Electronic Patient Reported Symptom Assessment
Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.
Status: Enrolling
Updated:  7/13/2015
Northwestern Memorial Hospital
mi
from
Chicago, IL
Electronic Patient Reported Symptom Assessment
Electronic Patient Reported Symptom Assessment: A Pilot Study Introducing Advanced Care Planning and Palliative Care to Hospitalized Women With Advanced Gynecologic, Breast, Thoracic, or Gastrointestinal Malignancies.
Status: Enrolling
Updated: 7/13/2015
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Mayo Clinic
mi
from
Jacksonville, FL
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Illinois Oncology Research Association
mi
from
Peoria, IL
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Wichita
mi
from
Wichita, KA
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Ochsner
mi
from
New Orleans, LA
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Ochsner
mi
from
New Orleans, LA
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Ann Arbor Regional
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Duluth
mi
from
Duluth, MN
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CentraCare Health Plaza
mi
from
Saint Cloud, MN
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CentraCare Health Plaza
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Medcenter One Health System
mi
from
Bismarck, ND
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Medcenter One Health System
mi
from
Bismarck, ND
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
Altru Health Systems
mi
from
Grand Forks, ND
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  7/13/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 7/13/2015
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials